Salivary biomarkers: Toward future clinical and diagnostic utilities

Clinical Microbiology Reviews

Volumn 26, Issue 4, 2013, Pages 781-791

  Yoshizawa, Janice M ^a   Schafer, Christopher A ^a   Schafer, Jason J ^b   Farrell, James J ^c   Paster, Bruce J ^d,e   Wong, David T W ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FORSYTH INSTITUTE   (United States)

^e HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RNA; RNA 16S;

BIOPSY; BLOOD SAMPLING; CHRONIC PANCREATITIS; CROHN DISEASE; DNA HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; INVASIVE PROCEDURE; LACTOBACILLUS; MICROBIOME; MOUTH CANCER; MOUTH DISEASE; OBESITY; PANCREAS CANCER; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SALIVARY GLAND; STREPTOCOCCUS MUTANS; SYSTEMIC DISEASE; TRANSCRIPTOMICS; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; DIAGNOSIS; DNA METHYLATION; GENE EXPRESSION PROFILING; HUMANS; INFECTION; MICROBIOTA; MOUTH; MOUTH DISEASES; PROTEOMICS; SALIVA; SALIVARY GLANDS; SALIVARY PROTEINS AND PEPTIDES;

EID: 84884957936     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00021-13     Document Type: Review

References (120)

1. Aas A, Jr, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-5732.
2. Bonne N, Wong D. 2012. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med. 4:82.
3. Park NJ, Li Y, Yu T, Brinkman BMN, Wong DT. 2006. Characterization of RNA in saliva. Clin. Chem. 52:988-994.
4. Hu S, Loo JA, Wong DT. 2007. Human saliva proteome analysis. Ann. N. Y. Acad. Sci. 1098:323-329.
5. Burbelo PD, Bayat A, Lebovitz EE, Iadarola MJ. 2012. New technologies for studying the complexity of oral diseases. Oral Dis. 18:121-126.
6. Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM. 2006. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem. Inst. Oswaldo Cruz 101:149-155.
7. Mager D, Haffajee A, Devlin P, Norris C, Posner M, Goodson J. 2005. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J. Transl. Med. 3:27.
8. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong D. 2010. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138:949-957.
9. Li Y, St John MAR, Zhou X, Kim Y, Sinha U, Jordan RCK, Eisele D, Abemayor E, Elashoff D, Park N-H, Wong DT. 2004. Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 10: 8442-8450.
10. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. 2008. Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 14:6246-6252.
11. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT. 2000. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin. Cancer Res. 6:2363-2370.
12. van Nieuw Amerongen A, Bolscher JGM, Veerman ECI. 2004. Salivary proteins: protective and diagnostic value in cariology? Caries Res. 38: 247-253.
13. Zalewska A, Zwierz K, Zółkowski K, Gindzień ski A. 2000. Structure and biosynthesis of human salivary mucins. Acta Biochim. Pol. 47:1067-1079.
14. Humphrey SP, Williamson RT. 2001. A review of saliva: normal composition, flow, and function. J. Prosthet. Dent. 85:162-169.
15. Edgar W. 1990. Saliva and dental health. Br. Dent. J. 169:96-98.
16. Tiwari M. 2011. Science behind human saliva. J. Nat. Sci. Biol. Med. 2:53-58.
17. Holsinger F, Bui D. 2007. Salivary gland disorders. Springer, Berlin, Germany.
18. Drobitch RK, Svensson CK. 1992. Therapeutic drug monitoring in saliva: an update. Clin. Pharmacokinet. 23:365-379.
19. Haeckel R, Hanecke P. 1993. The application of saliva, sweat, and tear fluid for diagnostic purposes. Ann. Biol. Clin. (Paris) 51:903-910.
20. Jusko WJ, Milsap RL. 1993. Pharmacokinetic principles of drug distribution in saliva. Ann. N. Y. Acad. Sci. 694:36-47.
21. Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG. 1995. Concise review. Saliva and growth factors: the fountain of youth resides in us all. J. Dent. Res. 74:1826-1832.
22. Rehak NN, Cecco SA, Csako G. 2000. Biochemical composition and electrolyte balance of "unstimulated" whole human saliva. Clin. Chem. Lab. Med. 38:335.
23. Campo J, Perea MA, Del Romero J, Cano J, Hernando V, Bascones A. 2006. Oral transmission of HIV, reality or fiction? An update. Oral Dis. 12:219-228.
24. Miller S. 1994. Saliva testing-a nontraditional diagnostic tool. Clin. Lab. Sci. 7:39-44.
25. Challacombe SJ, Percival RS, Marsh PD. 1995. Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals. Oral Microbiol. Immunol. 10:202-207.
26. Kozaki T, Lee S, Nishimura T, Katsuura T, Yasukouchi A. 2011. Effects of saliva collection using cotton swabs on melatonin enzyme immunoassay. J. Circadian Rhythms 9:1.
27. Navazesh M. 1993. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 694:72-77.
28. Silberring J, Ciborowski P. 2010. Biomarker discovery and clinical proteomics. Trends Anal. Chem. 29:128-140.
29. Ilyin SE, Belkowski SM, Plata-Salaman CR. 2004. Biomarker discovery and validation: technologies and integrative approaches. Trends Biotechnol. 22:411-416.
30. Wagner PD, Verma M, Srivastava S. 2004. Challenges for biomarkers in cancer detection. Ann. N. Y. Acad. Sci. 1022:9-16.
31. Kurian S, Grigoryev Y, Head S, Campbell D, Mondala T, Salomon DR. 2007. Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int. Immunopharmacol. 7:1948-1960.
32. Bonassi S, Neri M, Puntoni R. 2001. Validation of biomarkers as early predictors of disease. Mutat. Res. 480-481:349-358.
33. Haffajee AD, Socransky SS. 1994. Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000 5:78-111.
34. Paju S, Pussinen P, Suominen-Taipale L, Hyvönen M, Knuuttila M, Könönen E. 2009. Detection of multiple pathogenic species in saliva is associated with periodontal infection in adults. J. Clin. Microbiol. 47: 235-238.
35. Segata N, Haake S, Mannon P, Lemon K, Waldron L, Gevers D, Huttenhower C, Izard J. 2012. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 13:R42.
36. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The Human Microbiome Project. Nature 449:804-810.
37. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M. 2009. The NIH Human Microbiome Project. Genome Res. 19:2317-2323.
38. Zaura E, Keijser B, Huse S, Crielaard W. 2009. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol. 9:259. doi:10.1186/1471-2180-9-259.
39. Griffen AL, Beall CJ, Firestone ND, Gross EL, DiFranco JM, Hardman JH, Vriesendorp B, Faust RA, Janies DA, Leys EJ. 2011. CORE: a phylogenetically-curated 16S rDNA database of the core oral microbiome. PLoS One 6:e19051. doi:10.1371/journal.pone.0019051.
40. Nasidze I, Quinque D, Li J, Li M, Tang K, Stoneking M. 2009. Comparative analysis of human saliva microbiome diversity by barcoded pyrosequencing and cloning approaches. Anal. Biochem. 391:64-68.
41. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. 2001. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183:3770-3783.
42. Sakamoto M, Umeda M, Benno Y. 2005. Molecular analysis of human oral microbiota. J. Periodontal Res. 40:277-285.
43. Liu B, Faller LL, Klitgord N, Mazumdar V, Ghodsi M, Sommer DD, Gibbons TR, Treangen TJ, Chang Y-C, Li S, Stine OC, Hasturk H, Kasif S, Segrè D, Pop M, Amar S. 2012. Deep sequencing of the oral microbiome reveals signatures of periodontal disease. PLoS One 7:e37919. doi:10.1371/journal.pone.0037919.
44. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, Nelson KE, Gill SR, Fraser-Liggett CM, Relman DA. 2010. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 4:962-974.
45. Mandel I. 1987. The function of saliva. J. Dent. Res. 66:623-627.
46. Keijser BJF, Zaura E, Huse SM, van der Vossen JMBM, Schuren FHJ, Montijn RC, ten Cate JM, Crielaard W. 2008. Pyrosequencing analysis of the oral microflora of healthy adults. J. Dent. Res. 87:1016-1020.
47. Colombo APV, Boches SK, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst F, Paster BJ. 2009. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J. Periodontol. 80:1421-1432.
48. Colombo APV, Bennet S, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst FE, Paster BJ. 2012. Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray. J. Periodontol. 83:1279-1287.
49. Paster BJ, Dewhirst FE. 2009. Molecular microbial diagnosis. Periodontol. 2000 51:38-44.
50. Pozhitkov AE, Beikler T, Flemmig T, Noble PA. 2011. Highthroughput methods for analysis of the human oral microbiome. Periodontol. 2000 55:70-86.
51. Larmas M. 1975. A new dipslide technique for counting of salivary lactobacilli. Proc. Finn. Dent. Soc. 71:31-35.
52. Jordan HV, Laraway R, Snirch R, Marmel M. 1987. A simplified diagnostic system for cultural detection and enumeration of Streptococcus mutans. J. Dent. Res. 66:57-61.
53. Jensen B, Bratthall D. 1989. A new method for the estimation of mutans streptococci in human saliva. J. Dent. Res. 68:468-471.
54. Petersson GH, Bratthall D. 2000. Caries risk assessment: a comparison between the computer program 'Cariogram,' dental hygienists and dentists. Swed. Dent. J. 24:129-137.
55. Kneist S, Heinrich-Weltzien R, Fischer T, Klein C, Rupf S, Eschrich K. 1999. Handelsübliche Speicheltests zum Mutans-Nachweis-Ü bersicht und Effizienzbewertung. Quintessenz 50:33-43.
56. Glavina D, Gorseta K, Skrinjarić I, Vranić D, Mehulić K, Kozul K. 2012. Effect of LGG yoghurt on Streptococcus mutans and Lactobacillus spp. salivary counts in children. Coll. Antropol. 36:129-132.
57. Näse L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, Korpela R, Meurman JH. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 35:412-420.
58. Solemdal K, Sandvik L, Willumsen T, Mowe M, Hummel T. 2012. The impact of oral health on taste ability in acutely hospitalized elderly. PLoS One 7:e36557. doi:10.1371/journal.pone.0036557.
59. Bowden GH. 1997. Does assessment of microbial composition of plaque/saliva allow for diagnosis of disease activity of individuals? Community Dent. Oral Epidemiol. 25:76-81.
60. Lazarevic V, Whiteson K, Gaia N, Gizard Y, Hernandez D, Farinelli L, Osteras M, Francois P, Schrenzel J. 2012. Analysis of the salivary microbiome using culture-independent techniques. J. Clin. Bioinformatics 2:4. doi:10.1186/2043-9113-2-4.
61. Sakamoto M, Umeda M, Ishikawa I, Benno Y. 2000. Comparison of the oral bacterial flora in saliva from a healthy subject and two periodontitis patients by sequence analysis of 16S rDNA libraries. Microbiol. Immunol. 44:643-652.
62. Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. 2005. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J. Clin. Microbiol. 43:3944-3955.
63. Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, Uitto V-J, Paju S, Sorsa T. 2011. Use of host-and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis. Markers 30:299-305.
64. Takeshita T, Suzuki N, Nakano Y, Shimazaki Y, Yoneda M, Hirofuji T, Yamashita Y. 2010. Relationship between oral malodor and the global composition of indigenous bacterial populations in saliva. Appl. Environ. Microbiol. 76:2806-2814.
65. Luo AH, Yang DQ, Xin BC, Paster BJ, Qin J. 2012. Microbial profiles in saliva from children with and without caries in mixed dentition. Oral Dis. 18:595-601.
66. Paster BJ, Olsen I, Aas JA, Dewhirst FE. 2006. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol. 2000 42:80-87.
67. OraSure Technologies Inc. 2004. OraQuick advance rapid HIV-1/2 antibody test package insert. OraSure Technologies Inc., Bethlehem, PA.
68. Delaney KP, Branson BM, Uniyal A, Kerndt PR, Keenan PA, Jafa K, Gardner AD, Jamieson DJ, Bulterys M. 2006. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 20: 1655-1660.
69. OraSure Technologies Inc. 2013. OraSure HIV-1 Western blot kit package insert. OraSure Technologies Inc., Bethlehem, PA.
70. US Food and Drug Administration. July 2012. First rapid home-use HIV kitapprovedfor self-testing. FDAConsumerHealth Information. http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM311690.pdf. Accessed 6 May 2013.
71. Campsmith ML, Rhodes PH, Hall HI, Green TA. 2010. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J. Acquir. Immune Defic. Syndr. 53:619-624.
72. Marks G, Crepaz N, Janssen RS. 2006. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the U. S. A. AIDS 20:1447-1450.
73. Ahmed M, Islam M, Munshi S, Andalib S, Tabassum S. 2011. Testing hepatitis A virus antibody in oral fluid among the prospective vaccinees foster the need of new oral HAV rapid test. Indian J. Med. Microbiol. 29:72-73.
74. Oba IT, Spina AMM, Saraceni CP, Lemos MF, Senhoras R, Moreira RC, Granato CFH. 2000. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev. Inst. Med. Trop. Sao Paulo 42:197-200.
75. Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, Wu J, Wen SW. 2009. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int. J. Infect. Dis. 13:20-23.
76. Goncalves PL, Cunha CB, Busek SCU, Oliveira GC, Ribeiro-Rodrigues R, Pereira FE. 2005. Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies. Braz. J. Infect. Dis. 9:28-34.
77. Gonzalez V, Martro E, Folch C, Esteve A, Matas L, Montoliu A, Grifols JR, Bolao F, Tural C, Muga R, Parry JV, Ausina V, Casabona J. 2008. Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. Eur. J. Clin. Microbiol. Infect. Dis. 27:121-126.
78. OraSure Technologies Inc. 2010. Oraquick HCV rapid antibody test package insert. OraSure Technologies Inc., Bethlehem, PA.
79. Drobnik A, Judd C, Banach D, Egger J, Konty K, Rude E. 2011. Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. Am. J. Public Health 101:2151-2155.
80. Estevez P, Satoguina J, Nwakanma D, West S, Conway D, Drakeley C. 2011. Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malar. J. 10:104. doi:10.1186/1475-2875-10-104.
81. Yap G, Sil BK, Ng L-C. 2011. Use of saliva for early dengue diagnosis. PLoS Negl. Trop. Dis. 5:e1046. doi:10.1371/journal.pntd.0001046.
82. Eguchi J, Ishihara K, Watanabe A, Fukumoto Y, Okuda K. 2003. PCR method is essential for detecting Mycobacterium tuberculosis in oral cavity samples. Oral Microbiol. Immunol. 18:156-159.
83. Formenty P, Leroy EM, Epelboin A, Libama Fo Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C. 2006. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin. Infect. Dis. 42:1521-1526.
84. Furuta Y, Fukuda S, Chida E, Takasu T, Ohtani F, Inuyama Y, Nagashima K. 1998. Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J. Med. Virol. 54:162-166.
85. Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. 1998. Human herpesvirus 8 detection in nasal secretions and saliva. J. Infect. Dis. 177:213-216.
86. Gautheret A, Aubin JT, Fauveau V, Rozenbaum W, Huraux JM, Agut H. 1995. Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 14:820-824.
87. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Novak Z, Chowdhury N, Britt WJ, Fowler KB. 2011. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N. Engl. J. Med. 364:2111-2118.
88. Brodie EL, DeSantis TZ, Joyner DC, Baek SM, Larsen JT, Andersen GL, Hazen TC, Richardson PM, Herman DJ, Tokunaga TK, Wan JM, Firestone MK. 2006. Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl. Environ. Microbiol. 72:6288-6298.
89. Ballarini A, Segata N, Huttenhower C, Jousson O. 2013. Simultaneous quantification of multiple bacteria by the BactoChip microarray designed to target species-specific marker genes. PLoS One 8:e55764. doi: 10.1371/journal.pone.0055764.
90. Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A. 2012. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 18:935-942.
91. Michaud DS, Joshipura K, Giovannucci E, Fuchs CS. 2007. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl. Cancer Inst. 99:171-175.
92. Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. 2003. An exploration of the periodontitis-cancer association. Ann. Epidemiol. 13:312-316.
93. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, Virtamo J, Taylor PR, Albanes D. 2003. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am. J. Clin. Nutr. 78:176-181.
94. Farrell JJ ZL, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DT. 2012. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61:582-588.
95. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT. 2009. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15:5473-5477.
96. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT. 2007. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 56:3588-3600.
97. Lee Y-H, Kim J, Zhou H, Kim B, Wong D. 2012. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J. Mol. Med. 90:427-434.
98. Brinkmann O, Wong DT. 2011. Salivary transcriptome biomarkers in oral squamous cell cancer detection. Adv. Clin. Chem. 55:21-34.
99. Schulz BL, Cooper-White J, Punyadeera CK. 2012. Saliva proteome research: current status and future outlook. Crit. Rev. Biotechnol. 33: 246-259.
100. Kawas SA, Rahim ZHA, Ferguson DB. 2012. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch. Oral Biol. 57:1-9.
101. Spielmann N, Wong DT. 2011. Saliva: diagnostics and therapeutic perspectives. Oral Dis. 17:345-354.
102. Streckfus C, Bigler L. 2005. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv. Dent. Res. 18:17-24.
103. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. 2005. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J. Periodontol. 76:2075-2084.
104. Huang C-M. 2004. Comparative proteomic analysis of human whole saliva. Arch. Oral Biol. 49:951-962.
105. St John MA, Li Y, Zhou X, Denny P, Ho C, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park N, Liu H, Abemayor E, Wong DT. 2004. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 130:929-935.
106. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Roberts CT, Nagalla SR. 2009. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 8:239-245.
107. Landrum ML, Wilson CH, Perri LP, Hannibal SL, O'Connell RJ. 2005. Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid. Infect. Control Hosp. Epidemiol. 26:768-774.
108. Russo V. 1996. Epigenetic mechanisms of gene regulation, vol 32. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
109. Ohgane J, Yagi S, Shiota K. 2008. Epigenetics: the DNA methylation profile of tissue-dependent and differentially methylated regions in cells. Placenta 29(Suppl):29-35.
110. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349:2042-2054.
111. Viet CT, Schmidt BL. 2008. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol. Biomarkers Prev. 17:3603-3611.
112. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang W-W, Kim MM, Claybourne Q, Goldenberg D, Khan Z, Khan T, Westra WH, Sidransky D, Koch W, Califano JA. 2011. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin. Cancer Res. 17:4782-4789.
113. Righini CA, de Fraipont F, Timsit J-Fo Faure C, Brambilla E, Reyt E, Favrot M-C. 2007. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin. Cancer Res. 13:1179-1185.
114. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA. 2009. The relationship of DNA methylation with age, gender and genotype in twins and healthy Controls. PLoS One 4:e6767. doi:10.1371/journal.pone.0006767.
115. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu Y-Z, Plass C, Esteller M. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U. S. A. 102:10604-10609.
116. Bocklandt S, Lin W, Sehl ME, Sánchez F, Sinsheimer JS, Horvath S, Vilain E. 2011. Epigenetic predictor of age. PLoS One 6:e14821. doi:10.1371/journal.pone.0014821.
117. Lee H, Park M, Choi A, An J, Yang W, Shin K-J. 2012. Potential forensic application of DNA methylation profiling to body fluid identification. Int. J. Legal Med. 126:55-62.
118. Goodson JM, Groppo D, Halem S, Carpino E. 2009. Is obesity an oral bacterial disease? J. Dent. Res. 88:519-523.
119. Forde MD, Koka S, Eckert SE, Carr AB, Wong DT. 2006. Systemic assessments utilizing saliva. Part I. General considerations and current assessments. Int. J. Prosthodont. 19:43-52.
120. Haeckel R, Hänecke P. 1996. Application of saliva for drug monitoring: an in vivo model for transmembrane transport. Eur. J. Clin. Chem. Clin. Biochem. 34:171-191.